Remus Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0O5T01011
  • NSEID: REMUS
  • BSEID:
INR
736.40
16.45 (2.28%)
BSENSE

Dec 19

BSE+NSE Vol: 4200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRemus Pharma. VS Pharmaceuticals & Biotechnology
 
1D
2.28%
0.58%
1W
-2.29%
-0.31%
1M
0.88%
-0.33%
YTD
-41.03%
9.82%
1Y
-41.85%
8.41%
3Y
%
40.97%
5Y
%
88.7%
10Y
%
234.53%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.14%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.09%
0.06%
-8.03%
6 Months
-20.39%
0.11%
-20.28%
1 Year
-41.85%
0.08%
-41.77%
2 Years
-10.47%
0.64%
-9.83%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.5 per share ex-dividend date: Nov-14-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available